Celldex Therapeutics, Inc.
CLDX· Nasdaq
Released Aug 8, 2016, after the close
10-Q filed Aug 8, 2016, 39 days after period end · 0001104659-16-137913
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Revenue | $1.39M | $2.18M | $592.00K | $97.00K |
| EPS Diluted | -$0.32 | -$0.33 | -$0.32 | -$0.24 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Celldex Therapeutics, Inc. · CIK 744218 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Jun 30, 2016 · filed Aug 8, 2016 · 39 d after period end
+3.5% from the close of Aug 8, 2016 to the close of Aug 9, 2016, the first after the release.